Lack of response to multiple genotoxic agents at the hprt locus in peripheral blood T-lymphocytes of cynomolgus monkeys

Environmental and Molecular Mutagenesis

Volumn 33, Issue 2, 1999, Pages 123-131

  Zimmer, D M ^a   Harbach, P R ^a   Mattano, S S ^a   Yu, R L ^a   Mattes, W B ^a   Aaron, C S ^a  

^a PFIZER INC   (United States)

Author keywords

Cynomolgus monkey; Hprt; In vivo mutation; Nonhuman primate

Indexed keywords

ADOZELESIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESYLIC ACID ETHYL ESTER; RACHELMYCIN; TIOGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE LOCUS; GENOTOXICITY; MONKEY; MUTATION RATE; NONHUMAN; SOMATIC CELL GENETICS; T LYMPHOCYTE;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CYCLOHEXANECARBOXYLIC ACIDS; CYCLOHEXENES; CYCLOPHOSPHAMIDE; ETHYL METHANESULFONATE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INDOLES; LEUCOMYCINS; MACACA FASCICULARIS; MUTAGENS; T-LYMPHOCYTES;

ANIMALIA; MACACA FASCICULARIS; PRIMATES;

EID: 0032911640     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1999)33:2<123::AID-EM4>3.0.CO;2-7     Document Type: Article

References (25)

1. Aidoo A, Lyn-Cook LE, Mittelstadt RA, Heflich RH, Casciano DA. 1991. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ Mol Mutagen 17:141-151.
2. Albertini RJ. 1985. Somatic gene mutations as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutat Res 150:411-422.
3. Ammenheuser MM, Ward JB, Whorton EB, Killian JM, Legator MS. 1988. Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutat Res 204:509-520.
4. Cariello NF, Skopek TR. 1993. In vivo mutation at the human HPRT locus. Trend Genet 9(9):322-326.
5. Cole J, Skopek TR. 1994. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res 304:33-105.
6. Dempsey JL, Morley AA. 1986. Measurement of in vivo mutant frequency in lymphocytes of the mouse. Environ Mutagen 8:385-391.
7. Fuscoe JC, Zimmerman LJ, Harrington-Brock K, Moore MM. 1992. Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes. Mutat Res 283:255-262.
8. Fuscoe JC, Nelsen AJ, Pilia G. 1994. Detection of deletion mutations extending beyond the hprt gene by multiplex PCR analysis. Somat Cell Mol Genet 20:39-46.
9. Harbacn PR, Filipunas AL, Wang Y, Aaron CS. 1992. DNA sequence analysis of spontaneous and N-ethyl-N-nitrosourea induced hprt mutations arising in vivo in cynomolgus monkey T-lymphocytes. Environ Mol Mutagen 20:96-105.
10. Honma M, Hayashi M, Hackman P, Sofuni T. 1995. Chlorambucil-induced structural changes in the gpt gene of AS52 cells. Mutat Res 389: 199-205.
11. Jones IM, Burkhart-Schultz K, Strout CL, Crippen TL. 1987. Factors that affect the frequency of thioguanine-resistant lymphocytes in mice following exposure to ethylnitrosourea. Environ Mutagen 9:317-329.
12. Kataoka Y, Perrin J, Hunter N, Milas L, Grdina DJ. 1996. Antimutagenic effects of amifostine: clinical implications. Semin Oncol 23(4 Suppl 8):53-57.
13. Lippert MJ, Nicklas JA, Hunter TC, Albertini RJ. 1995. Pulsed field analysis of hprt T-cell large deletions: telomeric region breakpoint spectrum. Mutat Res 326:51-64.
14. Mattano SS, Zimmer DM, Harbach PR, Hunter TC, Aaron CS. 1995. Southern blot analysis of T-cell receptor gene rearrangements in cynomolgus monkeys and identification of a progenitor cell HPRT mutation. Environ Mol Mutagen 26:119-126.
15. Moore MM, Harrington-Brock K, Doerr CL, Dearfield KL. 1989. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagenesis 2:394-403
16. Nelson SL, Jones IM, Fuscoe JC, Burkhart-Schultz K, Grosovsky AJ. 1995. Mapping the end points of large deletions affecting the hprt locus in human peripheral blood cells. Radiat Res 141(1):2-10.
17. Palmer RG, Smith-Burchnell CA, Pelton BK, Hylton W, Denman AM. 1988. Use of T cell cloning to detect in vivo mutations induced by cyclophosphamide. Arthritis Rheum 31(6):757-761.
18. Savage JRK. 1975. Classification and relationships of induced chromosomal structural changes. J Med Genet 12:103-122.
19. Schmidt LH. 1960. Observations on the therapeutic activity and toxicity of 2-chloroethylmethane sulfonate-CB-1506 (NSC-18016). Cancer Chemother Rep 9:56-68.
20. vanDam FJ, Natarajan AT, Tates AD. 1992. Use of a t-lymphocyte clonal assay for determining hprt mutant frequencies in individual rats. Mutat Res 271:231-242.
21. Weiland KL, Dooley TP. 1991. In vitro and in vivo DNA bonding by the CC-1065 analog U-73975. Biochemistry 30:7559-7565.
22. Yu RL, Aronson M, Nichols WW. 1981. High resolution bands in human fibroblast chromosomes induced by actinomycin D. Cytogenet Cell Genet 31:111-114.
23. Zimmer DM, Aaron CS. 1987. Mutagenesis in vivo: preliminary experiments which confirm the feasibility of detection of ethylnitrosourea (ENU) mutagenesis in mouse T-lymphocytes. Environ Mutagen 9(S8):118
24. Zimmer DM, Aaron CS. 1997. In vivo mutagenesis in the cynomolgus monkey: time course of HPRT mutant frequency at long time points following ethylnitrosurea exposure. Environ Mol Mutagen 29:117-123.
25. Zimmer DM, Aaron CS, O'Neill JP, Albertini RJ. 1991. Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys). Environ Mol Mutagen 18:161-167.